[HN Gopher] Cancer pill AOH1996 shows promise in annihilating al...
       ___________________________________________________________________
        
       Cancer pill AOH1996 shows promise in annihilating all solid tumours
        
       Author : jjordan
       Score  : 32 points
       Date   : 2023-08-01 19:04 UTC (3 hours ago)
        
 (HTM) web link (www.prnewswire.com)
 (TXT) w3m dump (www.prnewswire.com)
        
       | thumbsup-_- wrote:
       | There is a new cancer cure every year for more than a decade now
       | but still nothing really substantiates in terms of saving
       | people's lives at scale. This research is promising but authors
       | of such news should feel morally obligated to also mention
       | realistically how far away in future will be the medicine based
       | on this research given that there are people out there with
       | limited time on their hands who might start getting their hopes
       | up by reading these.
        
         | blacksmith_tb wrote:
         | It's understandable to be frustrated by our lack of a magic
         | bullet to cure cancer, but unfortunately it's not one disease
         | but a whole range of different diseases. That said, I would
         | offer Checkpoint Inhibitors[1] as an example of a whole new
         | class of meds from recent years that have helped save many,
         | many people.
         | 
         | 1: https://www.cancer.gov/about-
         | cancer/treatment/types/immunoth...
        
         | Spooky23 wrote:
         | That's just not true.
         | 
         | Metastatic melanoma was a death sentence as little as 10 years
         | ago. Now, five year survival rates are improving thanks to
         | checkpoint inhibitors and improved radiosurgery.
        
       | skerit wrote:
       | I'd like to sign up my friend who has about 3 years left for some
       | clinical trials.
        
         | voldacar wrote:
         | If your friend's life is on the line and the evidence in favor
         | of this compound is good enough, just consider skipping the
         | process and having someone synthesize it for you.
        
           | 1letterunixname wrote:
           | Please don't spread false hope or impossible suggestions.
           | This molecule is still investigatory and proprietary, so
           | there's no documentation on its structure for replication by
           | anyone outside of original authors. Furthermore, it is highly
           | unlikely any researcher would jeopardize their reputation and
           | livelihood by randomly manufacturing experimental, unproven
           | compounds for clinical use.
        
             | sudosysgen wrote:
             | For better or for worse, there are services available
             | internationally which will manufacture experimental,
             | unproven, compounds for unspecified uses.
             | 
             | Additionally, proprietary investigational compounds
             | typically have their structure published in patents.
             | 
             | It's still a terribly bad idea to use experimental
             | compounds no matter how bad when they haven't even finished
             | safety trials - you wouldn't even be able to figure out
             | what dosage is going to be effective without killing you.
             | It's very easy to do far more harm than good. And typically
             | past Phase 1 trials when this is characterized,
             | compassionate use becomes a possibility.
        
       | joefigura wrote:
       | Link to paper here: https://www.cell.com/cell-chemical-
       | biology/fulltext/S2451-94...
        
       | adamredwoods wrote:
       | >> However, the cancer-killing pill Malkas has been developing
       | over the past two decades, AOH1996, targets a cancerous variant
       | of PCNA, a protein that in its mutated form is critical in DNA
       | replication and repair of all expanding tumors
       | 
       | But it's still a single pathway. Cancer has abilities to
       | circumvent most pathways, after a time.
       | 
       | Targeting multiple pathways will be the answer, but FDA is so
       | slow at allowing multiple-target clinical trials. Keytruda thus
       | far, has been the best to believe in combining with many other
       | products, and get clinical trials going. Sure, they have to
       | partner with competitors, but this (multi-pathways) is the true
       | path to stopping cancer.
        
       | westcort wrote:
       | Too early to draw any conclusions
        
         | 1letterunixname wrote:
         | Exactly. It's phase I testing. All they know is it doesn't seem
         | to kill mice or some healthy cells in a Petri dish. Despite
         | this being apparently a highly-targeted molecule, there is
         | always the potential for it to cause side-effects, injuries, or
         | fatalities in whole humans. It shows promise but wake me up
         | when it passes phase III.
        
       ___________________________________________________________________
       (page generated 2023-08-01 23:02 UTC)